XtalPi, which uses AI for drug discovery and development, raises $400M Series D led by OrbiMed and RRJ, at a valuation of over $2B (KrASIA)
KrASIA: XtalPi, which makes use of AI for drug discovery and improvement, raises $400M Sequence D led by OrbiMed and ...